Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain
- PMID: 39453657
- PMCID: PMC11581514
- DOI: 10.1001/jamanetworkopen.2024.38657
Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain
Abstract
Importance: Hepatitis C virus (HCV) microelimination aims to detect and treat hidden infections, especially in at-risk groups, like people experiencing homelessness (PEH) with alcohol or drug use disorders. Point-of-care HCV RNA testing and peer support workers are crucial for identifying and preventing HCV infection among marginalized populations, contributing to overall elimination goals.
Objective: To assess risk factors, prevalence, and trends of active HCV infection among PEH in Madrid, Spain (2019-2023).
Design, setting, and participants: This cross-sectional study was conducted between 2019 and 2023 in PEH, defined as people who lacked a fixed, regular, and adequate night residence, screened on the street or in homeless shelters via mobile unit using rapid HCV antibody testing, followed by HCV-RNA testing in Madrid, Spain. Data were analyzed from January to June 2024.
Main outcomes and measures: Active HCV infection among PEH was the main outcome. Risk factors analyzed included being born outside of Spain, alcohol misuse, lacking financial income, benzodiazepine use, injection drug use (IDU; including nonactive IDU and active IDU within the last year), opioid substitution therapy participation, and sexual behavior patterns. Data were analyzed using logistic regression. P values were adjusted for multiple testing using the false discovery rate (q-values).
Results: A total of 4741 individuals were screened for HCV infection, of whom 2709 (mean [SD] age, 42.2 [12.7]; 1953 [72.2%] men) were PEH and included in analysis. A total of 363 PEH (13.4%) had test results positive for HCV antibodies, of whom 172 (47.4%) had test results positive for HCV-RNA, and 148 of these (91.9%) started HCV treatment. Overall, active HCV infection prevalence was 6.3%, and the main risk factors associated with active HCV infection included IDU, encompassing both nonactive IDU (adjusted odds ratio [aOR], 10.9; 95% CI, 6.1-19.4; q < .001) and active IDU in the last year (aOR, 27.0; 95% CI, 15.2-48.0; q < .001); a lack of financial income (aOR, 1.8; 95% CI, 1.1-2.9; q = .03); and alcohol misuse (aOR, 1.8; 95% CI, 1.3-2.6; q = .008). There was a significant decrease between 2019 and 2023 in active HCV infection prevalence across the entire population, from 7.2% to 3.4% (P = .04).
Conclusions and relevance: In this cross-sectional study of PEH in Madrid, IDU, lack of income, and alcohol misuse were primary risk factors associated with HCV infection. The significant decline in HCV rates observed across all risk groups during the study period suggests preventive policies were effective in reducing HCV prevalence among the homeless population.
Conflict of interest statement
Figures




Similar articles
-
Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023.Euro Surveill. 2025 Jul;30(29):2500150. doi: 10.2807/1560-7917.ES.2025.30.29.2500150. Euro Surveill. 2025. PMID: 40709474 Free PMC article.
-
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.Lancet Glob Health. 2017 Dec;5(12):e1192-e1207. doi: 10.1016/S2214-109X(17)30375-3. Epub 2017 Oct 23. Lancet Glob Health. 2017. PMID: 29074409 Free PMC article.
-
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012021. doi: 10.1002/14651858.CD012021.pub2. Cochrane Database Syst Rev. 2017. PMID: 28922449 Free PMC article.
-
Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis.Public Health. 2008 Oct;122(10):990-1003. doi: 10.1016/j.puhe.2008.01.014. Epub 2008 May 19. Public Health. 2008. PMID: 18486955
-
Prevalence of hepatitis C virus seropositivity and active infection in a Rohingya refugee population in Cox's Bazar camps, Bangladesh: a cross-sectional study.Lancet Gastroenterol Hepatol. 2025 Jul;10(7):648-657. doi: 10.1016/S2468-1253(25)00094-9. Epub 2025 Apr 30. Lancet Gastroenterol Hepatol. 2025. PMID: 40318686
Cited by
-
Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023.Euro Surveill. 2025 Jul;30(29):2500150. doi: 10.2807/1560-7917.ES.2025.30.29.2500150. Euro Surveill. 2025. PMID: 40709474 Free PMC article.
References
-
- World Health Organization GHHaSPH . Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. Accessed September 5, 2024. https://www.who.int/publications/i/item/9789240053779
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical